
Adiso is a clinical-stage biopharmaceutical company dedicated to improving the health of patients suffering from debilitating inflammatory diseases by advancing a unique pipeline to treat Ulcerative Colitis and Inflammasome mediated disorders.
Address
ConcordMassachusetts
United States